Thomas J. Lynch, MD, director, Yale Cancer Center, physician-in-chief, Smilow Cancer Hospital at Yale-New Haven, discusses challenges associated with treating patients with lung cancer with molecular targeted therapies.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
Ещё видео!